SCHEMBL6094906

SCHEMBL6094906

CC(C)CCCCCCCCCCCCc1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
HIF1A Q16665 3/20 0.54
LMNA P02545 3/20 0.54
MAPT P10636 2/20 0.54
NFKB1 P19838 2/20 0.54
THPO P40225 2/20 0.54
PMP22 Q01453 2/20 0.54
GMNN O75496 1/20 0.54
CYP2D6 P10635 1/20 0.54
GABRA1 P14867 1/20 0.54
TSHR P16473 1/20 0.54
GABRA2 P47869 1/20 0.54
GABRB2 P47870 1/20 0.54
SLCO1B3 Q9NPD5 1/20 0.54
HDAC6 Q9UBN7 2/20 0.50
CYP3A4 P08684 3/20 0.42
ALOX15 P16050 2/20 0.42
ABCB11 O95342 1/20 0.42
CHRM2 P08172 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19732416 0.94 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL21523216 0.81 NPC1 (0.42) ALDH1A1SMN1; SMN2HIF1ALMNACYP3A4
SCHEMBL19732383 0.79 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL22594853 0.78 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL26242336 0.78 EGFR (0.57) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL8952467 0.77 ALDH1A1 (0.59) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL17806416 0.77 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
Hydrogen Peroxide SCHEMBL29262757 0.75 GRIN2D (0.49) ALDH1A1HIF1ALMNACYP3A4CHRM2
SCHEMBL7866210 0.75 CNR2 (0.44) ALDH1A1LMNAMAPTTSHRCYP3A4
SCHEMBL4266391 0.75 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7129366-B2 Group of a novel anti-cancer compounds with specific structure YANG'S BIOCHEM CO. LTD. (US) 2006-10-31 US claimed
US-20040204599-A1 Group of novel anti-cancer compounds with specific structure YANG'S BIOCHEM CO. LTD. 2004-10-14 US claimed
US-7129366-B2 Group of a novel anti-cancer compounds with specific structure YANG'S BIOCHEM CO. LTD. (US) 2006-10-31 US disclosed
US-20040204599-A1 Group of novel anti-cancer compounds with specific structure YANG'S BIOCHEM CO. LTD. 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204599-A1 Group of novel anti-cancer compounds with specific structure FASN, NFKBIA, NFATC1 ALDH1A1 3568/4885SMN1; SMN2 4760/4885HIF1A 1064/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.